Pitango

Santé is a leading early-stage venture capital firm founded in 2006, with offices in Austin and Boston. We invest at the intersection of science and technology, catalyzing disruptive opportunities across Biotech, MedTech and HealthTech. Combining extensive healthcare industry experience with deep scientific and technical expertise, we pursue innovative new opportunities to improve lives and generate returns. At Santé, we fuel entrepreneurs and form next-generation companies which shape the future of patient care, delivering better healthcare outcomes at a lower total cost to the system. Our expertise spans cellular biology, pharmaceutical drug development, device design and engineering, physician and hospital leadership, and public policy. Our investment philosophy of disciplined fund size, significant ownership positions, and diversified life sciences exposure has proven successful, as our funds have consistently generated top quartile returns for our investors. The firm has nearly $1BN under management and is investing out of Santé Health Ventures IV (a 2021 vintage fund) which follows the same successful investment strategy as our prior funds.

We are in the age of discovery, seizing a unique moment in time. Every generation experiences a breakthrough that alters the world. Technology has transformed virtually every aspect of our lives, and now it’s healthcare’s turn. aMoon is here to accelerate this transformation. We partner with exceptional entrepreneurs who harness groundbreaking science and technology to transform healthcare. Through aMoon Velocity and aMoon Growth, we invest in early and late-stage companies pursuing disruptive, cutting-edge solutions for high unmet medical needs. We build bridges between our portfolio companies and global tech, finance and medical research hubs to enable entrepreneurs to turn their vision into reality.

Our name, Sanara, resonates the Latin word Sanare, which means ‘To Heal and To Cure’, and ‘To Improve, Put-Right and Settle’. Sanare, for us, is an harmonious and visionary point of view on the future of health and well-being of people around the world. Sanara is a unique Israeli health-tech investment platform that focused on three main verticals: digital-health, bio-convergence and medical devices. Sanara consists of two investment vehicles, Sanara Ventures and Sanara Capital. Sanara Ventures is a seed-stage investment incubator-fund, supported by Philips and Teva Pharmaceuticals, and has 18 active startup companies on its portfolio. Sanara Capital, is an A-B round venture capital, that is doing follow-on investment to the best companies coming out of Sanara Ventures, as well as A-B round investments in external, non-Sanara related companies.

Positron Ventures helps and funds Europe-based scientist-entrepreneurs who are pursuing moonshots for (planetary) health. We invest in scientist-entrepreneurs working on a breakthrough in their field, across the natural sciences. We back teams from day one in their pursuit of solving a major global challenge. We do this with pre-seed investments and, wherever needed, support across all aspects of building a company. If you are looking for funding, check out our investment criteria and shopping list, and our view on when to engage. If you think there might be a match, contact us at startups@positron.vc. Scientists who have not yet spun out a company but are interested in doing so, please check our scientist resources.

Labena Ventures empowers CEE startups to scale globally. We take high-potential startup ventures on a fast-paced learning journey to help them explore and access business opportunities. Through highly-customized programmes, mentoring dedicated experts, as well as access to our vast network of business partners and investors, we help startups from all stages and across various industries on their way to international success. Labena Ventures, program aimed at scouting the most promising innovative startups and emerging companies throughout the Biotech, Pharma and Health value chains.

Harmonix invests in technological breakthroughs that will help create a future for a healthy, operational, and peaceful civilization. The fund focuses on exceptional entrepreneurs and innovative healthcare, life sciences, and deep tech companies. Harmonix is a multi-disciplinary team comprising scientists, researchers, operators, entrepreneurs, and industry experts with over 70 years of cumulative experience. Our diverse team provides founders with deep technical, operating, industry, and advisory expertise to accelerate and commercialize the next generation of technological advances. Harmonix accelerates scientific discoveries to advance human health and technology. We invest in companies that have functional solutions to real world problems. The Harmonix Process We deploy an evidence-based due diligence framework in assessing companies. Research: We identify opportunities ripe for innovation and examine areas where current standards of R&D, care, treatment, or workflow processes are inadequate. We find companies with functional solutions to problems that can create real value for stakeholders. Invest: We assess not only the technical dimensions of a venture, including supporting proof-of-concept data but also founder-fund fit. Our team looks for founders with emotional intelligence and demonstrated capacity for leadership and integrity. Accelerate: We support founders in all realms of the entrepreneurial process, including technical, operational, and business development support. We offer access to advisors who provide a level of expertise that is unavailable to many early-stage scientific companies.